Health ❯ Obesity

Treatment

Medications Pharmaceuticals Pharmacology Pharmacotherapy Wegovy GLP-1 Therapies Clinical Trials Weight-Loss Surgery Gene Therapy Chronic Disease Weight Loss Behavioral Interventions GLP-1 Medicines Investigational Drugs GLP-1 Drugs Medication Discontinuation Weight Loss Injections Pharmacological Interventions Individualized Approaches Medication

Major Reviews Find No Consistent Psychiatric Harm From GLP‑1 Diabetes and Weight‑Loss Drugs

Review authors say current observational evidence is mixed and only randomized trials with validated mood measures can determine causality.

GLP-1 Drugs Reshape Obesity Care

Experimental Antibody Preserves Muscle During Tirzepatide Weight Loss

DNA Links Found for Who Loses Weight and Who Gets Sick on GLP-1 Drugs

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

WHO Backs Long-Term GLP-1 Use for Obesity in First Global Guideline

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Phase 3 Trials Show Greater Weight Loss With 7.2 mg Injection and 25 mg Oral Semaglutide

Tufts Team Designs Experimental Four-Hormone Obesity Drug Aimed at Bigger, Gentler Weight Loss

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Obesity Disrupts Olfactory Pathway That Reduces Hunger in Mice